Risk of breast cancer following fertility treatment - A registry based cohort study of parous women in Norway

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1140-1148

  Reigstad, Marte Myhre ^a   Larsen, Inger Kristin ^b   Myklebust, Tor Åge ^b   Robsahm, Trude Eid ^b   Oldereid, Nan Birgitte ^a   Omland, Anne Katerine ^a   Vangen, Siri ^a   Brinton, Louise Annette ^c   Storeng, Ritsa ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ART; Assisted reproductive technology; Breast cancer; Cancer; Hormones; In vitro fertilization; IVF; Malignancy; Risk

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HAZARD RATIO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NORWAY; PARITY; PATIENT MONITORING; RISK ASSESSMENT; ADVERSE EFFECTS; BREAST NEOPLASMS; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; INCIDENCE; INFERTILITY, FEMALE; MIDDLE AGED; PREGNANCY; PROGNOSIS; REGISTER; RISK FACTOR;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MIDDLE AGED; NORWAY; PARITY; PREGNANCY; PROGNOSIS; REGISTRIES; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS;

EID: 84918795556     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29069     Document Type: Article

References (46)

1. Stephen EH, Chandra A. Updated projections of infertility in the United States: 1995-2025. Fertil Sterility 1998;70:30-4.
2. Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod 2013;28:2318-31.
3. Group ECW. Failures (with some successes) of assisted reproduction and gamete donation programs. Hum Reprod Update 2013;19:354-65.
4. Whittemore AS. The risk of ovarian cancer after treatment for infertility. N Engl J Med 1994;331:805-6.
5. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-203.
6. Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
7. Li LL, Zhou J, Qian XJ, et al. Meta-analysis on the possible association between in vitro fertilization and cancer risk. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 2013;23:16-24.
8. Brinton LA, Sahasrabuddhe VV, Scoccia B. Fertility drugs and the risk of breast and gynecologic cancers. Semin Reprod Med 2012;30:131-45.
9. Siristatidis C, Sergentanis TN, Kanavidis P, et al. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer - a systematic review and meta-analysis. Hum Reprod Update 2013;19:105-23.
10. Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012;156:635-48.
11. Dumitrescu RG, Cotarla I. Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 2005;9:208-21.
12. Cancer in Norway 2012 (2014)-Cancer incidence, mortality, survival and prevalence in Norway. Oslo.
13. Dunson DB, Colombo B, Baird DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002;17:1399-403.
14. Brinton L, Trabert B, Shalev V, et al. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Sterility 2013;99:1189-96.
15. Lerner-Geva L, Rabinovici J, Olmer L, et al. Are infertility treatments a potential risk factor for cancer development?. Perspective of 30 years of follow-up. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 2012;28:809-14.
16. Yli-Kuha AN, Gissler M, Klemetti R, et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012;27:1149-55.
17. Stewart LM, Holman CD, Hart R, et al. In vitro fertilization and breast cancer: is there cause for concern? Fertil Sterility 2012;98:334-40.
18. Dor J, Lerner-Geva L, Rabinovici J, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Sterility 2002;77:324-7.
19. Jensen A, Sharif H, Svare EI, et al. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidem Biomar 2007;16:1400-7.
20. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-90.
21. Kristiansson P, Bjor O, Wramsby H. Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod 2007;22:421-6.
22. Lerner-Geva L, Geva E, Lessing JB, et al. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 2003;13:23-7.
23. Brinton LA, Scoccia B, Moghissi KS, et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19:2005-13.
24. Katz D, Paltiel O, Peretz T, et al. Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study. Breast J 2008;14:517-22.
25. Pappo I, Lerner-Geva L, Halevy A, et al. The possible association between IVF and breast cancer incidence. Ann Surg Oncol 2008;15:1048-55.
26. Kallen B, Finnstrom O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod 2011;26:253-8.
27. Zreik TG, Mazloom A, Chen Y, et al. Fertility drugs and the risk of breast cancer: a metaanalysis and review. Breast Cancer Res Treat 2010;124:13-26.
28. Larsen I, Smastuen M, Johannesen T, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
29. Vikanes A, Magnus P, Vangen S, et al. Hyperemesis gravidarum in the Medical Birth Registry of Norway-a validity study. BMC Pregnancy Childbirth 2012;12:115.
30. Engeland A, Bjorge T, Daltveit AK, et al. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009;88:1083-9.
31. Zegers-Hochschild F, Adamson GD, De Mouzon J, et al. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod 2009;24:2683-7.
32. Out HJ, Mannaerts BM, Driessen SG, Bennink HJ. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-40.
33. Recombinant Human FSH Study Group. Clinical assessment of recombinant human folliclestimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant human FSH study group. Fertil Sterility 1995;63:77-86.
34. Hansmann M. Ultraschallbiometrie im II. und III. Trimester des Schwangerschaft. Gynäkologe 1976;9:133-155.
35. Schoenfeld D. Partial residuals for the proportional hazards regression-model. Biometrika 1982;69:239-41.
36. Commenges D, Letenneur L, Joly P, et al. Modelling age-specific risk: application to dementia. Stat Med 1998;17:1973-88.
37. Syse A, Kravdal O, Tretli S. Parenthood after cancer - a population-based study. Psycho-oncology 2007;16:920-7.
38. Stensheim H, Cvancarova M, Moller B, et al. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer J Int Cancer 2011;129:1225-36.
39. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP, 2013.
40. Silva Idos S, Wark PA, McCormack VA, et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 2009;100:1824-31.
41. Hudson N, Culley L, Blyth E, et al. Cross-border reproductive care: a review of the literature. Reprod Biomed Online 2011;22:673-85.
42. Orgeas CC, Sanner K, Hall P, et al. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol 2009;200:72 e1-7.
43. Hofvind S, Geller B, Vacek PM, et al. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007;22:447-55.
44. Gauthier E, Paoletti X, Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004;19:2216-21.
45. Brinton LA, Scoccia B, Moghissi KS, et al. Longterm relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarkers Prevent 2014;23:584-93.
46. Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hemat 2008;66:65-74.